Key considerations for mutation detection in CLL
Overview of CLL12 trial of ibrutinib aiming to delay chemoimmunotherapy
Next steps for advancing the molecular stratification of CLL
Can we apply knowledge on CLL to other types of cancers?
The importance of educating patients about adverse effects of treatment